Compare GE Vernova Inc (GEV) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs BIO-TECHNE Corp — how do they compare? GE Vernova Inc trades at $1,027.39 (market cap $283.57B), while BIO-TECHNE Corp trades at $71.46 (market cap $11.14B). The key difference: GE Vernova Inc is far larger — about 25.5× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays the higher dividend (0.45%). Which is the better fit depends on your goals.
| GEV | TECH | |
|---|---|---|
Market Cap | $283.57B | $11.14B |
Sector | Technology | Health |
52-Week High | $1.17K | $71.48 |
52-Week Low | $547.96 | $43.31 |
Enterprise Value | $276.21B | $11.22B |
Dividend Yield | 0.19% | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
